Improving the Odds for a Patient With Potentially Curable Stage IV Colorectal Cancer: A Question of Chemosensitivity

Por Grothey, Axel
Publicado em 2008

Medical treatment of advanced colorectal cancer in 2009

Por Grothey, Axel
Publicado em 2009

Adjuvant Therapy for Colon Cancer: Learning from the Past to Inform the Future

Por Sargent, Daniel, Grothey, Axel
Publicado em 2010

Antiangiogenesis therapy in the treatment of metastatic colorectal cancer

Por Grothey, Axel, Allegra, Carmen
Publicado em 2012

Metastatic extramammary Paget's disease responding to weekly paclitaxel

Por Phuoc, Vania, Grothey, Axel
Publicado no BMJ Case Rep (2015)

Molecular profiling in the treatment of colorectal cancer: focus on regorafenib

Por Yan, Yiyi, Grothey, Axel
Publicado no Onco Targets Ther (2015)

European Society for Medical Oncology Copenhagen update: potential practice-changing findings

Por Mallarkey, Gordon, Grothey, Axel
Publicado no Ther Adv Med Oncol (2016)

Antiangiogenic therapy for refractory colorectal cancer: current options and future strategies

Por Riechelmann, Rachel, Grothey, Axel
Publicado no Ther Adv Med Oncol (2016)

Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumab

Por Kim, George P, Grothey, Axel
Publicado em 2008

Should Oncologists Routinely Discuss Fertility Preservation With Cancer Patients of Childbearing Age?

Por Coleman, Shawnta L., Grothey, Axel
Publicado em 2011

Waiting in Line for Cancer Treatments?

Por Gonsalves, Wilson I., Grothey, Axel
Publicado em 2011

Establishing a Standard of Care for Small Bowel Adenocarcinomas: Challenges and Lessons Learned

Por Halfdanarson, Thorvardur R., Grothey, Axel
Publicado em 2012

Systemic Therapy for Elderly Patients with Gastrointestinal Cancer

Por Hubbard, Joleen M., Grothey, Axel, Sargent, Daniel J.
Publicado em 2011

Drug rechallenge and treatment beyond progression—implications for drug resistance

Por Kuczynski, Elizabeth A., Sargent, Daniel J., Grothey, Axel, Kerbel, Robert S.
Publicado no Nat Rev Clin Oncol (2013)

Systemic cytotoxic and biologic therapies for colorectal cancer liver metastases: expert consensus statement

Por Clary, Bryan M, Grothey, Axel, Kopetz, Scott, Marsh, Robert D W
Publicado em 2013

The search for treatments to reduce chemotherapy-induced peripheral neuropathy

Por Pachman, Deirdre R., Loprinzi, Charles L., Grothey, Axel, Ta, Lauren E.
Publicado em 2013

Adaptive randomized phase II design for biomarker threshold selection and independent evaluation

Por Renfro, Lindsay A., Coughlin, Christina M., Grothey, Axel M., Sargent, Daniel J.
Publicado no Chin Clin Oncol (2014)

Tumor Status at 12 Weeks Predicts Survival in Advanced Colorectal Cancer: Findings from NCCTG N9741

Por Heun, James M., Grothey, Axel, Branda, Megan E., Goldberg, Richard M., Sargent, Daniel J.
Publicado em 2011

Hepatic Artery Embolization for Neuroendocrine Tumors: Postprocedural Management and Complications

Por Lewis, Mark A., Jaramillo, Sylvia, Roberts, Lewis, Fleming, Chad J., Rubin, Joseph, Grothey, Axel
Publicado em 2012

Evaluation of Alternate Categorical Tumor Metrics and Cut Points for Response Categorization Using the RECIST 1.1 Data Warehouse

Por Mandrekar, Sumithra J., An, Ming-Wen, Meyers, Jeffrey, Grothey, Axel, Bogaerts, Jan, Sargent, Daniel J.
Publicado em 2014